Xian, YLiang, LPeterson, ED2020-10-272020-10-272012-10-030098-74841538-3598https://hdl.handle.net/10161/21643Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineTISSUE-PLASMINOGEN ACTIVATORINTRACEREBRAL HEMORRHAGETHROMBOLYSISBleeding risk with ischemic stroke therapy - ReplyJournal article2020-10-27